Rare diseases Marathon sells Duchenne drug to PTC PTC says it will make changes to the price after abandoned launch last month.
News US drug revenues far exceed R&D spend - report Analysis questions industry's rationale for high US prices.
News Concordia and Actavis face UK pricing probe Firms colluded to hike prices, says competition watchdog.
News J&J: drug price rises below 10% since 2012 Janssen unit responds to criticism from president Trump over pricing.
News Pfizer under investigation over links with charities US authorities probing several other drugmakers amid pricing row.
News Pharma must slash rare disease drug prices - patient organis... More rare disease drugs must also be approved, says EURORDIS.
News Isomorphic Labs raises $5bn in massive third round In yet another sign of the appetite for AI companies among investors, Isomorphic Labs has raised a whopping $5bn in a Series C financing.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.